Nice, France

Rémi Delansorne

This inventor holds 1 USPTO granted patent. Top assignee: Laboratoire Theramex. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rémi Delansorne. Retrieved from https://idiyas.com/inventor/randeacutemi-delansorne

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rémi Delansorne: Innovator in Peptide Analogues

Introduction

Rémi Delansorne is a notable inventor based in Nice, France. He has made significant contributions to the field of pharmaceuticals, particularly through his work on peptide analogues. His innovative approach has led to advancements that could impact various therapeutic applications.

Latest Patents

Delansorne holds a patent for "LH-RH peptide analogues, their uses and pharmaceutical compositions containing them." This patent highlights his expertise in developing compounds that may have important implications in medical treatments.

Career Highlights

Currently, Rémi Delansorne is associated with Laboratoire Theramex, where he continues to push the boundaries of pharmaceutical research. His work has been instrumental in advancing the understanding and application of peptide analogues in medicine.

Collaborations

Delansorne collaborates with Jacques Paris, another professional in the field, to further enhance the research and development of innovative pharmaceutical solutions.

Conclusion

Rémi Delansorne's contributions to the field of peptide analogues exemplify the impact of dedicated inventors in advancing medical science. His work at Laboratoire Theramex continues to pave the way for future innovations in pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…